Key result
A BMI reduction of ≥0.42 or waist circumference reduction of ≥3.0 cm over 1 year significantly reduced the incidence of micro-/macroalbuminuria in men with baseline albuminuria.
Why the study?
Do changes in obesity parameters (BMI or waist circumference) affect the incidence or resolution of chronic kidney disease components in Japanese individuals?
Cohort
Do changes in obesity parameters (BMI or waist circumference) affect the incidence or resolution of chronic kidney disease components in Japanese individuals?
Reducing obesity parameters over a 1-year period can improve albuminuria, while weight gain increases the risk of developing CKD components in men.
Answers are grounded in this paper and cite their sources.
May support obesity reduction in men with albuminuria; leaves open causal effects on CKD progression.
Obesity increases the risk for chronic kidney disease (CKD). By analyzing data on individuals who underwent general health screening in two consecutive years, we investigated whether changes in body mass index (BMI) or waist circumference (WC) were associated with the appearance or disappearance of the CKD components; micro-/macroalbuminuria (> or =30 mg urinary albumin per gram creatinine) and a low estimated glomerular filtration rate (eGFR; <60 ml/min/1.73 m(2)). Logistic regression analysis showed that in men with micro-/macroalbuminuria at the first visit, a BMI reduction of > or =0.42 or a WC reduction of > or =3.0 cm over the 1-year period resulted in a significantly reduced incident of micro-/macroalbuminuria at the second visit. On the other hand, a BMI gain of > or =0.33 over 1 year in men without micro-/macroalbuminuria and a low eGFR at the fist visit significantly increased the incident of micro-/macroalbuminuria and a low eGFR, respectively, at the second visit. These findings indicate that lowering the obesity indexes in men with micro-/macroalbuminuria reduced the incidence of this condition at the 1-year follow-up and that, on the contrary, an increase in BMI in men without micro-/macroalbuminuria and a low eGFR at the first examination increased the risk of these conditions during the 1-year follow-up period.
No takes yet. Share an insight, caveat, or question.
Ishizaka et al. (2009) conducted a cohort in Chronic Kidney Disease. Changes in body mass index (BMI) or waist circumference (WC) was evaluated on Appearance or disappearance of CKD components (micro-/macroalbuminuria and low eGFR). A BMI reduction of ≥0.42 or waist circumference reduction of ≥3.0 cm over 1 year significantly reduced the incidence of micro-/macroalbuminuria in men with baseline albuminuria.
Synapse has enriched 10 related papers. Consider them for comparative context: